ALT - Altimmune - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALT is currently covered by 7 analysts with an average price target of $20.56. This is a potential upside of $12.31 (149.21%) from yesterday's end of day stock price of $8.25.

Altimmune's activity chart (see below) currently has 60 price targets and 75 ratings on display. The stock rating distribution of ALT is 92.31% BUY and 7.69% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.14% with an average time for these price targets to be met of 35.1 days.

Highest price target for ALT is $25, Lowest price target is $12, average price target is $20.56.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 14-Nov-2024. First documented stock forecast 01-Jun-2020.

Currently out of the existing stock ratings of ALT, 24 are a BUY (92.31%), 2 are a HOLD (7.69%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$3.75 (45.45%)

$12

1 months 7 days ago
(14-Nov-2024)

0/12 (0%)

$3.12 (35.14%)

Buy

$20

$11.75 (142.42%)

$20

4 months 9 days ago
(12-Aug-2024)

4/16 (25%)

$13.78 (221.54%)

214

Buy

$25

$16.75 (203.03%)

$25

6 months ago
(21-Jun-2024)

3/13 (23.08%)

$18.59 (290.02%)

42

Buy

$24

$15.75 (190.91%)

$16

7 months 11 days ago
(10-May-2024)

0/13 (0%)

$16.78 (232.41%)

Hold

$26

7 months 22 days ago
(29-Apr-2024)

0/5 (0%)

$12.36 (90.62%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALT (Altimmune) average time for price targets to be met?

On average it took 35.1 days on average for the stock forecasts to be realized with a an average price target met ratio 13.14

Which analyst has the current highest performing score on ALT (Altimmune) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on ALT (Altimmune)?

Mayank Mamtani works at B. RILEY and has 24 price targets and 16 ratings on ALT

Which analyst is the currently most bullish on ALT (Altimmune)?

Roger Song with highest potential upside - $26.75

Which analyst is the currently most reserved on ALT (Altimmune)?

Kelechi Chikere with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?